 Motus GI Holdings, Inc., NASDAQ: MOTS Motus GI or the Company, a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, today announced that it is relocating its corporate headquarters from Fort Lauderdale, Fl. to Boston in Q2 2020. 